Determinants of Delayed Presentation and Advanced-Stage Diagnosis of Breast Cancer in Africa: A Systematic Review and Meta-Analysis
- PMID: 33906291
- PMCID: PMC8325140
- DOI: 10.31557/APJCP.2021.22.4.1007
Determinants of Delayed Presentation and Advanced-Stage Diagnosis of Breast Cancer in Africa: A Systematic Review and Meta-Analysis
Abstract
Background/objective: Breast cancer (BC) mortality is exceptionally high in Africa due to late presentation and advanced-stage diagnosis. Previous studies examining barriers to early BC presentation are markedly inconsistent, showing conflicting findings within and between African regions, making resource allocation and designing interventional campaigns challenging. Our objective was to assess the strength or magnitude of the association between determinants/risk factors and delayed presentation/advanced-stage diagnosis of BC in Africa.
Methods: Electronic searches in PubMed, AJOL, Google, ResearchGate, ScienceDirect, and PubMed Central found eligible articles between 2000 and 2020. The meta-analytical procedure in Meta-XL used the quality effect model. I-squared (I2) above 75% indicated high heterogeneity. The summary effect size was the odds ratio with 95% confidence intervals.
Results: The effect of socio-economic and demographic determinants on delay varies across African regions. Low level of education (1.63, 95% CI 1.01-2.63), and not performing breast self examination (BSE) (13.59, 95% CI 3.33-55.4) were significantly associated with delayed presentation. Younger patients had more significant delays in West Africa (WA, 1.41, 95%CI 1.08-1.85), and the reverse occurred in North Africa (0.68, 95%CI 0.48-0.97). Lack of BC knowledge (1.59, 95% CI 1.29-1.97), not performing BSE, or no history of undergoing clinical breast examination (CBE) (2.45, 95% CI 1.60-3.40), were associated with advanced-stage disease at diagnosis. Older patients had significantly more advanced disease in WA, and the reverse occurred in South Africa. Aggressive molecular BC subtypes [Triple negative (OR 1.62, 95% CI 1.27-2.06) or HER2 positive (1.56, 95% CI 1.10-2.23)] were significant determinants of advanced-stage diagnosis.
Conclusion: Promoting early presentation and reducing advanced-stage BC throughout Africa should focus on modifiable factors, including providing quality education, improving breast health awareness and BC knowledge, and developing strategies to increase BSE and CBE. Interventions targeting socio-demographic determinants should be context-specific.
Keywords: Advanced-stage; Africa; Meta-analysis; breast cancer; delay.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort.PLoS One. 2023 Feb 16;18(2):e0281916. doi: 10.1371/journal.pone.0281916. eCollection 2023. PLoS One. 2023. PMID: 36795733 Free PMC article.
-
Determinants of delay in diagnosis and end stage at presentation among breast cancer patients in Iran: a multi-center study.Sci Rep. 2020 Dec 8;10(1):21477. doi: 10.1038/s41598-020-78517-6. Sci Rep. 2020. PMID: 33293634 Free PMC article.
-
Determinants of late detection and advanced-stage diagnosis of breast cancer in Nigeria.PLoS One. 2021 Nov 3;16(11):e0256847. doi: 10.1371/journal.pone.0256847. eCollection 2021. PLoS One. 2021. PMID: 34731161 Free PMC article.
-
Late-stage diagnosis: The driving force behind high breast cancer mortality in Ethiopia: A systematic review and meta-analysis.PLoS One. 2024 Jul 19;19(7):e0307283. doi: 10.1371/journal.pone.0307283. eCollection 2024. PLoS One. 2024. PMID: 39028722 Free PMC article.
-
Advanced-stage breast cancer diagnosis and its determinants in Ethiopia: a systematic review and meta-analysis.BMC Womens Health. 2024 May 11;24(1):284. doi: 10.1186/s12905-024-03133-9. BMC Womens Health. 2024. PMID: 38734607 Free PMC article.
Cited by
-
Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort.PLoS One. 2023 Feb 16;18(2):e0281916. doi: 10.1371/journal.pone.0281916. eCollection 2023. PLoS One. 2023. PMID: 36795733 Free PMC article.
-
Experiences of cancer-related stigma in Africa: A scoping review.Int J Cancer. 2025 Jun 15;156(12):2265-2282. doi: 10.1002/ijc.35376. Epub 2025 Feb 25. Int J Cancer. 2025. PMID: 39998387 Free PMC article.
-
Predictors of survival among breast cancer patients in Ethiopia: a systematic review and meta-analysis.Front Oncol. 2025 Apr 3;14:1459613. doi: 10.3389/fonc.2024.1459613. eCollection 2024. Front Oncol. 2025. PMID: 40248001 Free PMC article.
-
Availability and geographic access to breast cancer pathology services in Ghana.PLoS One. 2024 Aug 14;19(8):e0305901. doi: 10.1371/journal.pone.0305901. eCollection 2024. PLoS One. 2024. PMID: 39141634 Free PMC article.
-
Ethnobotanical Survey of Medicinal Plants Used in Breast Cancer Treatment by Traditional Health Practitioners in Central Uganda.J Multidiscip Healthc. 2023 Mar 8;16:635-651. doi: 10.2147/JMDH.S387256. eCollection 2023. J Multidiscip Healthc. 2023. PMID: 36919184 Free PMC article.
References
-
- Abuidris DO, Elsheikh A, Ali M, et al. Breast-cancer screening with trained volunteers in a rural area of Sudan: a pilot study. Lancet Oncol. 2013;14:363–70. - PubMed
-
- Adly S, Hewedi IH, Mokhtar NM. Clinicopathologic significance of molecular classification of breast cancer: relation to nottingham prognosis index. J Egypt Natl Canc Inst. 2010;22:209–15. - PubMed
-
- Agbo SP, Khalid A, Oboirien M. Clinical presentation, prevalence and management of breast cancer in Sokoto, Nigeria. J Womens Health Care. 2015;3:149.
-
- Agodirin O, Olatoke S, Rahman G, et al. Delay between breast cancer detection and arrival at specialist clinic preliminary revelations of multicentered survey in Nigeria. Texila Int Jl Public Health. 2017;5 DOI: .21522/TIJPH.2013.05.04.Art053.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous